Synonyms: ACP-044 | ACP044 | compound 1 [WO2020159643A1] [1]
Compound class:
Synthetic organic
Comment: The chemical structure for ebaresdax is claimed in Cersci Therapeutics' patent WO2020159643A1 [1], which allowed us to associate this structure with their clinical lead candidate ACP-044. This was confirmed by synonym matches on PubChem. Ebaresdax (ACP-044) is a first-in-class, orally administered, non-opioid analgesic that was developed for potential to treat neuropathic, surgical and osteoarthritic pain.
|
|
References |
1. Dax S. (2020)
Methods of treating pain with a thiazoline anti-hyperalgesic. Patent number: WO2020159643A1. Assignee: Cersci Therapeutics, Inc.. Priority date: 01/02/2019. Publication date: 06/08/2020. |